Interferons [clinicaltrials_resource:ac14a704eab186e8681cb6c21160bdb2]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV Infection [clinicaltrials:NCT00000647]Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma [clinicaltrials:NCT00000687]A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma [clinicaltrials:NCT00000694]Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma [clinicaltrials:NCT00000695]A Phase I/II Open Label Study To Evaluate the Antiviral Potential of Combination Low-Dose Therapy With Zidovudine and Interferon-Alpha 2A in Patients With Symptomatic HIV Disease [clinicaltrials:NCT00000696]A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma [clinicaltrials:NCT00000725]A Randomized Phase II Study of Two Doses of Interferon Alfa-2a (IFN Alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3 [clinicaltrials:NCT00000754]Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-Infected Children [clinicaltrials:NCT00000761]Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection. [clinicaltrials:NCT00000764]A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3 [clinicaltrials:NCT00000844]The Safety of Zidovudine Plus Interferon-Alpha in HIV-Infected Children [clinicaltrials:NCT00000967]A Study of Tumor Necrosis Factor and Human Interferon-gamma in Patients With AIDS Related Complex [clinicaltrials:NCT00001004]The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections [clinicaltrials:NCT00001035]The Safety and Effectiveness of Injections of Human Recombinant Interferon-gamma in Patients With AIDS Who Have Taken Zidovudine [clinicaltrials:NCT00001112]A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma [clinicaltrials:NCT00001113]The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma [clinicaltrials:NCT00001114]Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer [clinicaltrials:NCT00001228]A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma [clinicaltrials:NCT00001296]A Phase IV Study of Recombinant Human Gamma Interferon in Patients With Chronic Granulomatous Diseases of Childhood [clinicaltrials:NCT00001317]Treatment of Non-Tuberculous Mycobacterial Infections With Interferon Gamma [clinicaltrials:NCT00001318]clinicaltrials:NCT00001379Interferon Gamma for Drug Resistant Tuberculosis [clinicaltrials:NCT00001407]Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM) [clinicaltrials:NCT00001785]Interferon Gamma to Treat Leukocyte Adhesion Deficiency Type I [clinicaltrials:NCT00001905]Double-Blind, Randomized, Placebo-Controlled Study of Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived) in ARC Patients [clinicaltrials:NCT00002012]Double-Blind, Randomized, Dose Ranging Study of Alferon LDO (Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)) in HIV+ Subjects [clinicaltrials:NCT00002018]Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus (HIV) Infection [clinicaltrials:NCT00002078]A Randomized Trial to Evaluate the Safety and Efficacy of Combination Therapy With Retrovir ( AZT ) and HIVID ( ddC ) Versus Retrovir, HIVID, and Wellferon ( Interferon Alfa-n1 ) for the Treatment of HIV Infection [clinicaltrials:NCT00002086]Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT Regimen [clinicaltrials:NCT00002238]A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection [clinicaltrials:NCT00002270]The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS [clinicaltrials:NCT00002299]The Effects of r-metHuIFN-Gamma on the Lungs of Patients With AIDS [clinicaltrials:NCT00002433]Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid Tumors [clinicaltrials:NCT00002470]Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer [clinicaltrials:NCT00002475]Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer [clinicaltrials:NCT00002504]Tumor Cell Vaccine in Treating Patients With Advanced Cancer [clinicaltrials:NCT00002505]Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer [clinicaltrials:NCT00002506]clinicaltrials:NCT00002548Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma [clinicaltrials:NCT00002556]Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002574]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Interferons [clinicaltrials_resource:ac14a704eab186e8681cb6c21160bdb2]
Bio2RDF identifier
ac14a704eab186e8681cb6c21160bdb2
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ac14a704eab186e8681cb6c21160bdb2
identifier
clinicaltrials_resource:ac14a704eab186e8681cb6c21160bdb2
title
Interferons
@en
type
label
Interferons [clinicaltrials_resource:ac14a704eab186e8681cb6c21160bdb2]
@en